TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
McGill University Health Centre
New treatment option for latent tuberculosis
February 10th, 2009
This release is available in French. Montreal, December 31st, 2008 – Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease. The latest study by Dr. Dick Menzies of the Research Institute of the McGill University Health Centre (MUHC) describes a new potential treatment for this particular form of TB. The paper based on this study was recently published in the Annals of Internal Medicine. "Our results show that a four-month treatment with a drug called rifampin is better tolerated than the traditional nine-month treatment...
Source: TB & Outbreaks Week (2009-02-10)
|
